You can't make a silk purse out of a sow's ear. If the drug doesn't fundamentally work then DEPing it won't help much.
The best SPL can do here is capitalise on the publicity of its capability to to quickly (SPL? quick?) improve a drug by making it easier to administer to patients.
- Forums
- ASX - By Stock
- SPL
- Ann: SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2
Ann: SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2, page-131
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.4¢ |
Change
0.001(1.08%) |
Mkt cap ! $38.73M |
Open | High | Low | Value | Volume |
9.4¢ | 9.6¢ | 9.2¢ | $11.66K | 123.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28393 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.6¢ | 2593 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28393 | 0.093 |
1 | 247718 | 0.092 |
1 | 48440 | 0.091 |
2 | 80000 | 0.090 |
1 | 400000 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.096 | 2593 | 1 |
0.098 | 19848 | 1 |
0.099 | 630 | 1 |
0.100 | 52000 | 2 |
0.105 | 92396 | 2 |
Last trade - 14.37pm 03/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online